Serina Therapeutics, Inc. (SER) earnings
SER earnings moved a median of -1.45% by the close. Quarterly and annual SER reports and results, each read against the price at its own news timestamp. Back to the SER overview →
19 measured SER earnings events.
Where these SER earnings landedvs 15 measured SER earnings reactions
| Middle 50% of SER earnings reactions | -3.64% to 0.00% |
|---|---|
| Median reaction (to close) | -1.45% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 SER earnings events with a measured close landed between -3.64% and +0.00%; 20% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Serina Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +6.06% | |
| Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates | Press release | +0.00% | +6.06% | |
| Form 10-Q Serina Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +3.33% | -0.61% | |
| Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates | Press release | +3.33% | -0.61% | |
| Form 10-K/A Serina Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.11% | +0.44% | |
| Form 10-K Serina Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -3.98% | -5.43% | |
| Form 10-Q Serina Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights | Press release | +0.00% | — | |
| Form 10-Q Serina Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +3.43% | — | |
| Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights | Press release | +3.43% | — | |
| Form 10-Q Serina Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.58% | -2.93% | |
| Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights | Press release | -0.58% | -2.93% | |
| Form 10-K Serina Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.62% | -4.35% | |
| Form 10-Q Serina Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights | Press release | +0.00% | +0.00% | |
| Form 10-Q Serina Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | -8.98% | |
| Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights | Press release | — | -8.98% | |
| Form 10-Q Serina Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +2.57% | -1.45% | |
| Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights | Press release | +2.57% | -1.45% |
Keep exploring
More SER: analyst actions → · SEC filings → · SER overview →